What does progression mean for Lung Cancer and what happens next

Understanding Progression in Lung Cancer

Progression is an important term you'll hear from your oncology team. Let me explain what it means and what typically happens next.

What Does Progression Mean?

Progression means that your lung cancer is growing or spreading despite treatment. Your doctor determines this by comparing imaging tests (like CT scans) over time. Progression can show up as:

• Existing tumors getting larger
• New tumors appearing in the lungs or other parts of your body
• New symptoms developing that suggest cancer growth

According to the NCCN Guidelines for Non-Small Cell Lung Cancer, doctors assess for progression by doing CT scans of your chest, abdomen, and pelvis regularly—typically after every 2-4 cycles of treatment during initial therapy, and every 6-12 weeks during maintenance therapy.

Why Progression Matters

Progression tells your oncology team that your current treatment isn't controlling the cancer effectively. This is actually important information because it helps guide the next steps in your care. It doesn't mean treatment has "failed"—it means your doctor needs to adjust the strategy.

What Happens Next: The General Approach

When progression occurs, oncologists typically follow a structured decision-making process:

STEP 1: Evaluate the Type of Progression

Your doctor will determine:

• Where the cancer is progressing (brain, lungs, other organs)
• How much is progressing (limited areas vs. widespread)
• How fast it's progressing

According to NCCN Guidelines, this evaluation is critical because it determines your next treatment options.

STEP 2: Consider Testing for Resistance Mechanisms

This is a key step many patients don't expect. When cancer progresses on targeted therapy (like EGFR inhibitors or ALK inhibitors), your doctor may recommend:

• Biopsy of a progressing lesion to check if the cancer has changed
• Plasma or tissue-based molecular testing to identify why the cancer is resisting your current treatment
• Testing for specific mutations that may have developed

The NCCN Guidelines note that approximately 6% of patients with EGFR-mutant lung cancer can develop small cell lung cancer transformation—a different type of cancer that requires different treatment. This is why re-testing at progression is so important.

STEP 3: Determine Your Next Treatment

Your treatment options depend on several factors:

If you have an EGFR mutation and progressed on first-generation EGFR inhibitors:

• You may be eligible for osimertinib (a third-generation EGFR inhibitor) if you developed the T790M resistance mutation
• Or other targeted therapies based on what your testing shows

If you have an ALK rearrangement and progressed on one ALK inhibitor:

• According to NCCN Guidelines, preferred options include alectinib, brigatinib, ensartinib, or lorlatinib
• The specific choice depends on which ALK inhibitor you previously received and what resistance mutations developed

If you have limited progression (only a few new spots):

• Your doctor may recommend continuing your current targeted therapy AND adding local treatment like:
  • SABR (stereotactic ablative radiation therapy—high-dose focused radiation)
  • Surgery to remove specific lesions
  • SRS (stereotactic radiosurgery) if the progression is in the brain

If you have widespread progression:

• You may switch to chemotherapy combined with immunotherapy
• Or try a different targeted therapy if one is available for your specific mutation

Important Considerations

Brain Metastases: If progression includes new brain tumors, your doctor will coordinate brain-specific treatments (like radiation or surgery) with systemic therapy. The NCCN Guidelines emphasize that the timing and sequencing of these treatments matters.

Beware of "Flare Phenomenon": The NCCN Guidelines note that some patients experience a temporary worsening of symptoms when stopping a targeted therapy. If this happens, your doctor may restart the previous therapy while planning the next step.

Questions to Ask Your Oncology Team

When your doctor tells you about progression, these questions can help you understand your specific situation:

1. "Where exactly is the cancer progressing, and how much has it grown?"
2. "Do you recommend any testing (biopsy or blood tests) to understand why the cancer is progressing?"
3. "What are my treatment options, and which do you recommend for my specific situation?"
4. "Can we combine my current treatment with local therapy (radiation or surgery) for the progressing areas?"
5. "What is the goal of the next treatment—to control the cancer, manage symptoms, or something else?"
6. "How will we monitor whether the new treatment is working?"

The Bottom Line

Progression is a change in your treatment plan, not an end to treatment options. Modern lung cancer care has many sequential therapies available. Your oncologist's job is to match the right treatment to your cancer's specific characteristics at each stage.

According to the NCCN Guidelines, the approach to progression is systematic and evidence-based—your doctor will use your test results and imaging to guide the next steps specifically for YOUR cancer.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.